Market cap
$12,719 Mln
Revenue (TTM)
$8,330 Mln
P/E Ratio
249.8
P/B Ratio
1.3
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
1.8 %
-
Industry P/E
--
-
EV/EBITDA
22.4
-
Debt to Equity
0.2
-
Book Value
$--
-
EPS
$0.9
-
Face value
--
-
Shares outstanding
77,154,209
10 Years Aggregate
CFO
$4,582.19 Mln
EBITDA
$6,817.54 Mln
Net Profit
$3,242.57 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ICON - ADR
| -7.1 | 2.0 | 17.1 | 2.3 | -12.2 | -8.1 | 8.5 |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
ICON - ADR
| -13.1 | 45.7 | -37.3 | 58.8 | 13.2 | 33.3 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout ICON - ADR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development,... management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland. Read more
-
Founder & Independent Non-Executive Director
Dr. John Climax Ph.D.
-
Founder & Independent Non-Executive Director
Dr. John Climax Ph.D.
-
Headquarters
Dublin
-
Website
FAQs for ICON - ADR
What is the current share price of ICON plc - ADR Today?
The share price of ICON plc - ADR is $169.31 (NASDAQ) as of 11-Sep-2026 16:00 EDT. ICON plc - ADR has given a return of -12.2% in the last 3 years.
What is the current PB & PE ratio of ICON plc - ADR?
The P/E ratio of ICON plc - ADR is 249.77 times as on 04-Sep-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
60.84 |
1.52 |
2024 |
21.79 |
1.81 |
2023 |
38.42 |
2.55 |
2022 |
31.70 |
1.88 |
2021 |
167.46 |
3.18 |
What is the 52 Week High and Low of ICON plc - ADR?
The 52-week high and low of ICON plc - ADR are Rs 203.91 and Rs 66.57 as of 12-Sep-2026.
What is the market cap of ICON plc - ADR?
ICON plc - ADR has a market capitalisation of $ 12,719 Mln as on 04-Sep-2026. As per SEBI classification, it is a company.
Should I invest in ICON plc - ADR?
Before investing in ICON plc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.